Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Nicolas Lecrenier, Alen Marijam, Jan Olbrecht, Lamine Soumahoro, Javier Nieto Guevara & Bruce Mungall. (2020) Ten years of experience with the pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine (Synflorix) in children. Expert Review of Vaccines 19:3, pages 247-265.
Read now
Read now
Nicola Principi & Susanna Esposito. (2018) Development of pneumococcal vaccines over the last 10 years. Expert Opinion on Biological Therapy 18:1, pages 7-17.
Read now
Read now
Michael E. Pichichero. (2017) Pneumococcal whole-cell and protein-based vaccines: changing the paradigm. Expert Review of Vaccines 16:12, pages 1181-1190.
Read now
Read now
Susanna Esposito & Nicola Principi$suffix/text()$suffix/text(). (2017) Strategies to develop vaccines of pediatric interest. Expert Review of Vaccines 16:2, pages 175-186.
Read now
Read now
Philippe Hermand, Annick Vandercammen, Emmanuel Mertens, Emmanuel Di Paolo, Vincent Verlant, Philippe Denoël & Fabrice Godfroid. (2017) Preclinical evaluation of a chemically detoxified pneumolysin as pneumococcal vaccine antigen. Human Vaccines & Immunotherapeutics 13:1, pages 220-228.
Read now
Read now
Articles from other publishers (27)
Jeremy A. Duke & Fikri Y. Avci. (2023) Emerging vaccine strategies against the incessant pneumococcal disease. npj Vaccines 8:1.
Crossref
Crossref
Pedro H. Silva, Yaneisi Vázquez, Camilo Campusano, Angello Retamal-Díaz, Margarita K. Lay, Christian A. Muñoz, Pablo A. González, Alexis M. Kalergis & Susan M. Bueno. (2022) Non-capsular based immunization approaches to prevent Streptococcus pneumoniae infection. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Crossref
Robert K. M. Choy, A. Louis Bourgeois, Christian F. Ockenhouse, Richard I. Walker, Rebecca L. Sheets & Jorge Flores. (2022) Controlled Human Infection Models To Accelerate Vaccine Development. Clinical Microbiology Reviews 35:3.
Crossref
Crossref
Javid Aceil & Fikri Y. Avci. (2022) Pneumococcal Surface Proteins as Virulence Factors, Immunogens, and Conserved Vaccine Targets. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Crossref
Paulina Kaplonek, Ling Yao, Katrin Reppe, Franziska Voß, Thomas Kohler, Friederike Ebner, Alexander Schäfer, Ulrike Blohm, Patricia Priegue, Maria Bräutigam, Claney L. Pereira, Sharavathi G. Parameswarappa, Madhu Emmadi, Petra Ménová, Martin Witzenrath, Sven Hammerschmidt, Susanne Hartmann, Leif E. Sander & Peter H. Seeberger. (2022) A semisynthetic glycoconjugate provides expanded cross-serotype protection against Streptococcus pneumoniae. Vaccine 40:7, pages 1038-1046.
Crossref
Crossref
Giuliana S. Oliveira, Maria Leonor S. Oliveira, Eliane N. Miyaji & Tasson C. Rodrigues. (2021) Pneumococcal Vaccines: Past Findings, Present Work, and Future Strategies. Vaccines 9:11, pages 1338.
Crossref
Crossref
Kelly M. Martinovich, Tasmina Rahman, Camilla de Gier, Elke J. Seppanen, Tilda Orami, Caitlyn M. Granland, Jacinta Francis, Mition Yoannes, Karli J. Corscadden, Rebecca Ford, Peter Jacoby, Anita H. J. van den Biggelaar, Lauren O. Bakaletz, Allan W. Cripps, Deborah Lehmann, Peter C. Richmond, William S. Pomat, Lea-Ann S. Kirkham & Ruth B. Thornton. (2021) Differences in Pneumococcal and Haemophilus influenzae Natural Antibody Development in Papua New Guinean Children in the First Year of Life. Frontiers in Immunology 12.
Crossref
Crossref
Ann Thanawastien, Kelsey E. Joyce, Robert T. Cartee, Laurel A. Haines, Stephen I. Pelton, Rodney K. Tweten & Kevin P. Killeen. (2021) Preclinical in vitro and in vivo profile of a highly-attenuated, broadly efficacious pneumolysin genetic toxoid. Vaccine 39:11, pages 1652-1660.
Crossref
Crossref
Julio Sempere, Mirella Llamosí, Idoia del Río Menéndez, Beatriz López Ruiz, Mirian Domenech & Fernando González-Camacho. (2021) Pneumococcal Choline-Binding Proteins Involved in Virulence as Vaccine Candidates. Vaccines 9:2, pages 181.
Crossref
Crossref
Malihe Masomian, Zuleeza Ahmad, Lai Ti Gew & Chit Laa Poh. (2020) Development of Next Generation Streptococcus pneumoniae Vaccines Conferring Broad Protection. Vaccines 8:1, pages 132.
Crossref
Crossref
Mark R. Alderson, Tim Murphy, Stephen I. Pelton, Laura A. Novotny, Laura L. Hammitt, Arwa Kurabi, Jian-Dong Li, Ruth B. Thornton & Lea-Ann S. Kirkham. (2020) Panel 8: Vaccines and immunology. International Journal of Pediatric Otorhinolaryngology 130, pages 109839.
Crossref
Crossref
D. E. Briles, J. C. Paton, R. Mukerji, E. Swiatlo & M. J. Crain. (2019) Pneumococcal Vaccines. Microbiology Spectrum 7:6.
Crossref
Crossref
Laura L. Hammitt, James C. Campbell, Dorota Borys, Robert C. Weatherholtz, Raymond Reid, Novalene Goklish, Lawrence H. Moulton, Magali Traskine, Yue Song, Kristien Swinnen, Mathuram Santosham & Katherine L. O'Brien. (2019) Efficacy, safety and immunogenicity of a pneumococcal protein-based vaccine co-administered with 13-valent pneumococcal conjugate vaccine against acute otitis media in young children: A phase IIb randomized study. Vaccine 37:51, pages 7482-7492.
Crossref
Crossref
D. E. Briles, J. C. Paton, R. Mukerji, E. Swiatlo & M. J. Crain. 2019. Gram-Positive Pathogens. Gram-Positive Pathogens
362
377
.
Kawaguchiya, Urushibara, Aung, Shinagawa, Takahashi & Kobayashi. (2019) Prevalence of Various Vaccine Candidate Proteins in Clinical Isolates of Streptococcus pneumoniae: Characterization of the Novel Pht Fusion Proteins PhtA/B and PhtA/D. Pathogens 8:4, pages 162.
Crossref
Crossref
Aderonke Odutola, Martin O.C. Ota, Martin Antonio, Ezra O. Ogundare, Yauba Saidu, Patrick K. Owiafe, Archibald Worwui, Olubukola T. Idoko, Olumuyiwa Owolabi, Beate Kampmann, Brian M. Greenwood, Mark Alderson, Magali Traskine, Kristien Swinnen, Vincent Verlant, Kurt Dobbelaere & Dorota Borys. (2019) Immunogenicity of pneumococcal conjugate vaccine formulations containing pneumococcal proteins, and immunogenicity and reactogenicity of co-administered routine vaccines – A phase II, randomised, observer-blind study in Gambian infants. Vaccine 37:19, pages 2586-2599.
Crossref
Crossref
Alfonso Carmona Martinez, Roman Prymula, Mariano Miranda Valdivieso, Maria del Carmen Otero Reigada, Jose Manuel Merino Arribas, Jerzy Brzostek, Leszek Szenborn, Renata Ruzkova, Michael R. Horn, Teresa Jackowska, Fernando Centeno-Malfaz, Magali Traskine, Kurt Dobbelaere & Dorota Borys. (2019) Immunogenicity and safety of 11- and 12-valent pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccines (11vPHiD-CV, 12vPHiD-CV) in infants: Results from a phase II, randomised, multicentre study. Vaccine 37:1, pages 176-186.
Crossref
Crossref
Giora I. Morozov, Nurith Porat, Tatyana Kushnir, Hastyar Najmuldeen, Asad Adawi, Vered Chalifa-Caspi, Rachel Benisty, Ariel Ohayon, Ofir Liron, Shalhevet Azriel, Itai Malka, Shahar Dotan, Maxim Portnoi, Andrew A. Piotrowski, Daniel Kafka, Barak Hajaj, Tali Fishilevich, Marilou Shagan, Michael Tal, Ron Ellis, Donald A. Morrison, Andrea M. Mitchell, Timothy J. Mitchell, Ron Dagan, Hasan Yesilkaya & Yaffa Mizrachi Nebenzahl. (2018) Flavin Reductase Contributes to Pneumococcal Virulence by Protecting from Oxidative Stress and Mediating Adhesion and Elicits Protection Against Pneumococcal Challenge. Scientific Reports 8:1.
Crossref
Crossref
Salvador F. Ausar, Kavisha Jayasundara, Lamees Akawi, Cristopher Roque, Anthony Sheung, Jian Hu, Marina Kirkitadze & Nausheen Rahman. (2017) Biophysical Characterization and Thermal Stability of Pneumococcal Histidine Triad Protein D in the Presence of Zinc and Manganese. Journal of Pharmaceutical Sciences 106:10, pages 2979-2987.
Crossref
Crossref
Roman Prymula, Leszek Szenborn, Sven-Arne Silfverdal, Jacek Wysocki, Piotr Albrecht, Magali Traskine, Asparuh Gardev, Yue Song & Dorota Borys. (2017) Safety, reactogenicity and immunogenicity of two investigational pneumococcal protein-based vaccines: Results from a randomized phase II study in infants. Vaccine 35:35, pages 4603-4611.
Crossref
Crossref
Aderonke Odutola, Martin O.C. Ota, Martin Antonio, Ezra O. Ogundare, Yauba Saidu, Ebenezer Foster-Nyarko, Patrick K. Owiafe, Fatima Ceesay, Archibald Worwui, Olubukola T. Idoko, Olumuyiwa Owolabi, Abdoulie Bojang, Sheikh Jarju, Isatou Drammeh, Beate Kampmann, Brian M. Greenwood, Mark Alderson, Magali Traskine, Nathalie Devos, Sonia Schoonbroodt, Kristien Swinnen, Vincent Verlant, Kurt Dobbelaere & Dorota Borys. (2017) Efficacy of a novel, protein-based pneumococcal vaccine against nasopharyngeal carriage of Streptococcus pneumoniae in infants: A phase 2, randomized, controlled, observer-blind study. Vaccine 35:19, pages 2531-2542.
Crossref
Crossref
Lea-Ann S. Kirkham, Selma P. Wiertsema, Karli J. Corscadden, Tulia Mateus, Gemma L. Mullaney, Guicheng Zhang, Peter C. Richmond & Ruth B. Thornton. (2017) Otitis-Prone Children Produce Functional Antibodies to Pneumolysin and Pneumococcal Polysaccharides. Clinical and Vaccine Immunology 24:3.
Crossref
Crossref
Claudia Trappetti & James C. Paton. (2017) Host-to-Host Transmission of the Pneumococcus—New Victims of a Toxic Relationship. Cell Host & Microbe 21:1, pages 5-6.
Crossref
Crossref
M. Ammar Zafar, Yang Wang, Shigeto Hamaguchi & Jeffrey N. Weiser. (2017) Host-to-Host Transmission of Streptococcus pneumoniae Is Driven by Its Inflammatory Toxin, Pneumolysin. Cell Host & Microbe 21:1, pages 73-83.
Crossref
Crossref
Kendra M. Damer, Carrie M. Maffeo, Deborah Zeitlin, Carrie M. Jung & Medhane G. Cumbay. 2017. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions
301
330
.
Bruno Corsini, Leire Aguinagalde, Susana Ruiz, Mirian Domenech, María Luisa Antequera, Asunción Fenoll, Pedro García, Ernesto García & Jose Yuste. (2016) Immunization with LytB protein of Streptococcus pneumoniae activates complement-mediated phagocytosis and induces protection against pneumonia and sepsis. Vaccine 34:50, pages 6148-6157.
Crossref
Crossref
Yukihiro Akeda & Kazuyoshi Ikuta. (2015) VII. Next Generation Pneumococcal Vaccine. Nihon Naika Gakkai Zasshi 104:11, pages 2351-2356.
Crossref
Crossref